Try our mobile app
Screener
Company
Price and
change
Revenue Growth
last / hist
EV /
LTM
EBITDA
(p75)
EV/
Sales
EBITDA LTM
/ Revenue
FCF LTM
/ Revenue
Next GAAP report
Year div-d yield
FCF Yield LTM
200.0%  /
23.4%
15.4x
12.5x
4.5x
29.5%
0.0%
..
3.2%
--- 
200.0%  /
22.8%
1.6x
5.4x
1.5x
90.9%
83.7%
..
83.1%
384.7% 
33.3%  /
18.3%
11.4x
14x
9.1x
80.0%
-9.3%
2027-02-05
7.3%
-2.4% 
10.3%  /
17.3%
10.2x
13.4x
9.2x
90.1%
288.1%
2027-02-25
3.2%
31.6% 
16.9%  /
16.7%
18.7x
20.4x
15.3x
82.2%
19.0%
2027-02-11
3.0%
1.7% 
-5.9%  /
10.7%
12.9x
19.5x
12.2x
94.2%
53.5%
2027-02-13
4.1%
7.8% 
19.6%  /
8.6%
20.3x
19.1x
14.5x
71.6%
-45.7%
..
3.9%
-4.3% 
5.5%  /
8.3%
16.5x
15.6x
10.6x
64.3%
-15.6%
..
2.1%
-2.3% 
1.9%  /
7.5%
16.2x
16.2x
11.2x
68.8%
79.4%
2027-02-13
4.1%
10.2% 
7.9%  /
7.5%
11.3x
11.7x
6.3x
55.5%
0.0%
..
2.2%
--- 
8.7%  /
6.8%
8.9x
15.3x
8.2x
92.1%
69.4%
2027-02-11
5.9%
8.4% 
-21.3%  /
6.5%
15.9x
15.9x
12.5x
78.5%
12.6%
2026-11-05
4.0%
1.4% 
5.3%  /
6.5%
14.3x
16.9x
11x
77.1%
-1.5%
2027-02-13
4.0%
-0.2% 
1.2%  /
5.8%
8.7x
8.7x
6.4x
73.5%
43.2%
..
0.0%
6.7% 
19.8%  /
5.0%
23.8x
22.4x
11.9x
50.1%
15.1%
..
2.7%
2.1% 
4.6%  /
4.2%
16x
15.5x
11x
68.8%
32.0%
..
4.1%
4.4% 
1.5%  /
4.0%
2.7x
3.5x
2.6x
97.4%
0.0%
..
8.2%
--- 
1.8%  /
3.6%
13.9x
13.8x
8.7x
62.2%
-30.5%
..
7.2%
-5.6% 
12.1%  /
2.5%
8.2x
10.6x
6.8x
83.6%
49.1%
2027-02-26
3.6%
8.2% 
0.0%  /
2.1%
10.6x
11.4x
8.6x
81.0%
67.1%
..
12.8%
14.7% 
-50.0%  /
-33.4%
>200x
>200x
8.8x
-281.8%
-136.4%
..
0.0%
-16.0% 
Trending screeners:
@electric-vehicles
@saas
@cannabis-players
@china
Latin America
India
Dividends
@REITs
@adtech
@airlines
@artificial-intelligence
@auto-parts
@cloud-computing
@crypto
@cybersecurity
@e-commerce
@edtech
@finance-and-technology
@gaming
@internet-of-things
@oil-refining
@real-estate-tech
@renewable-energy
@vaccine-makers

Reviews

2026-11-06
#reports #SU

[Suncor Energy](https://eninvs.com/all.php?name=SU) (Oil and Gas Integrated) reported for 2026 q3
(2026-05-05, After Market Close):

- Revenue +50.6% YoY (vs +48.3% in previous quarter and historical rate +7.0%)
- EBITDA +93.5% YoY (vs +107.1% in previous quarter and historical rate +9.9%)
- EBITDA margin 39.2% increased compared to 30.5% same period last year
- Net Debt decreased by $1.9 bln since the start of the year (2.0% of market cap)
- FCF (LTM) +$8.8 bln (positive), 9.4% of market cap
- EV/EBITDA multiple is 5.5x compared to historical level (75th percentile) of 6.3x
- EV/Sales multiple is 1.9x

2026-11-06
#reports #YELP

[Yelp](https://eninvs.com/all.php?name=YELP) (Crowdsourcing platform) reported for 2026 q3
(2026-05-07, After Market Close):

- Revenue -1.3% YoY (vs +1.6% in previous quarter and historical rate +4.1%)
- EBITDA +29.2% YoY (vs -6.1% in previous quarter and historical rate +45.9%)
- EBITDA margin 22.6% increased compared to 17.3% same period last year
- Net Debt decreased by $52 mln over the past reporting period (4.6% of market cap)
- FCF (LTM) -$0.1 bln (negative), 6.6% of market cap
- EV/EBITDA multiple is 4.3x compared to historical level (75th percentile) of 14.3x
- EV/Sales multiple is 0.7x

2026-11-06
#reports #XRAY

[DENTSPLY SIRONA](https://eninvs.com/all.php?name=XRAY) (Dental materials and equipment manufacturer) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=203777)
(2026-05-05, After Market Close):

- Revenue -7.5% YoY (vs -4.1% in previous quarter and historical rate +0.2%)
- EBITDA margin 13.0% increased compared to -20.1% same period last year
- Net Debt increased by $34 mln over the past reporting period (1.7% of market cap)
- FCF (LTM) +$0.1 bln (positive), 3.7% of market cap
- EV/EBITDA multiple is 27.2x compared to historical level (75th percentile) of 213.7x
- EV/Sales multiple is 1x

2026-11-06
#reports #XPOF

[Xponential Fitness, Inc.](https://eninvs.com/all.php?name=XPOF) (Leisure) reported for 2026 q3
(2026-05-07, After Market Close):

- Revenue -21.5% YoY (vs -13.2% in previous quarter and historical rate -2.5%)
- EBITDA +200% YoY (vs -38.9% in previous quarter and historical rate +31.1%)
- EBITDA margin 33.9% increased compared to 8.9% same period last year
- Net Debt decreased by $3 mln over the past reporting period (1.6% of market cap)
- FCF (LTM) -$0.1 bln (negative), 27.3% of market cap
- EV/EBITDA multiple is 22.7x compared to historical level (75th percentile) of 66.1x
- EV/Sales multiple is 3.4x

2026-11-06
#reports #XERS

[Xeris Pharmaceuticals](https://eninvs.com/all.php?name=XERS) (Biotechnology) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=203719)
(2026-05-07, Before Market Open):

- Revenue +98.1% YoY (vs +91.7% in previous quarter and historical rate +58.0%)
- EBITDA margin 15.9% increased compared to -14.8% same period last year
- Net Debt decreased by $73 mln over the past reporting period (3.1% of market cap)
- FCF (LTM) -$0 bln (negative), 0.9% of market cap
- EV/EBITDA multiple is 52.4x compared to historical level (75th percentile) of 91.3x
- EV/Sales multiple is 6.6x

2026-11-06
#reports #WSC

[WillScot](https://eninvs.com/all.php?name=WSC) (Warehouse service provider) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=203637)
(2026-05-07, After Market Close):

- Revenue +6% YoY (vs +3.9% in previous quarter and historical rate -0.2%)
- EBITDA -0.5% YoY (vs -11.6% in previous quarter and historical rate +5.1%)
- EBITDA margin 33.4% decreased compared to 35.6% same period last year
- Net Debt decreased by $46 mln over the past reporting period (1.4% of market cap)
- FCF (LTM) +$0.2 bln (positive), 5.1% of market cap
- EV/EBITDA multiple is 15.1x compared to historical level (75th percentile) of 16.4x
- EV/Sales multiple is 3x

2026-11-06
#reports #WRBY

[Warby Parker Inc.](https://eninvs.com/all.php?name=WRBY) (Medical Instruments and Supplies) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=203577)
(2026-05-07, Before Market Open):

- Revenue +10.4% YoY (vs +10.3% in previous quarter and historical rate +12.7%)
- EBITDA 0% YoY (vs +200.0% in previous quarter and historical rate +106.0%)
- EBITDA margin 5.3% decreased compared to 5.9% same period last year
- Net Debt increased by $19 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) -$0 bln (negative), 0.8% of market cap
- EV/EBITDA multiple is 75.1x compared to historical level (75th percentile) of 164.8x
- EV/Sales multiple is 3.5x

2026-11-06
#reports #WK

[Workiva](https://eninvs.com/all.php?name=WK) (Software — Application) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=203557)
(2026-05-05, After Market Close):

- Revenue +17.4% YoY (vs +18.6% in previous quarter and historical rate +18.3%)
- EBITDA margin 7.6% increased compared to -0.4% same period last year
- Net Debt decreased by $74 mln over the past reporting period (1.6% of market cap)
- FCF (LTM) +$0.2 bln (positive), 4.7% of market cap
- EV/EBITDA multiple is 72.5x compared to historical level (75th percentile) of 408.4x
- EV/Sales multiple is 4.5x

2026-11-06
#reports #WHG

[Westwood Group](https://eninvs.com/all.php?name=WHG) (Capital Markets) reported for 2026 q3
(2026-04-30, After Market Close):

- Revenue +3.8% YoY (vs +4.2% in previous quarter and historical rate +16.3%)
- Net Income +50% YoY (vs +100.0% in previous quarter)
- Net Income margin 11.1% increased compared to 7.7% same period last year
- P/E multiple is 20x compared to historical level (75th percentile) of 69x
- P/S multiple is 1.6x
- Price to book: 1.3x
2026-11-06
#reports #WEN

[Wendys](https://eninvs.com/all.php?name=WEN) (Restaurants) reported for 2026 q3
(2026-05-08, Before Market Open):

- Revenue -0.5% YoY (vs +1.8% in previous quarter and historical rate +0.4%)
- EBITDA -33.7% YoY (vs -24.0% in previous quarter and historical rate -15.5%)
- EBITDA margin 11.2% decreased compared to 16.7% same period last year
- Net Debt decreased by $46 mln over the past reporting period (3.1% of market cap)
- FCF (LTM) +$0.2 bln (positive), 10.6% of market cap
- EV/EBITDA multiple is 18.9x compared to historical level (75th percentile) of 18.1x
- EV/Sales multiple is 2.3x

2026-11-06
#reports #WD

[Walker & Dunlop](https://eninvs.com/all.php?name=WD) (Financial service providers) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=203574)
(2026-05-07, Before Market Open):

- Revenue +15.5% YoY (vs +37.7% in previous quarter and historical rate -3.6%)
- Net Income -144% YoY (vs -96.6% in previous quarter and historical rate -26.4%)
- Net Income margin -12.4% decreased compared to 32.6% same period last year
- P/E multiple is 17.4x compared to historical level (75th percentile) of 8.2x
- P/S multiple is 1.1x
- Price to book: 0.8x
2026-11-06
#reports #VXRT

[Vaxart](https://eninvs.com/all.php?name=VXRT) (Influenza vaccine manufacturer) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=203762)
(2026-05-07, After Market Close):

- Revenue +57.1% YoY (vs +400.0% in previous quarter and historical rate +92.3%)
- EBITDA margin -145.5% increased compared to -1028.6% same period last year
- Net Debt decreased by $54 mln over the past reporting period (58.3% of market cap)
- FCF (LTM) -$0 bln (negative), 4.3% of market cap
- EV/Sales multiple is 1.4x

2026-11-06
#reports #VTRS

[Viatris](https://eninvs.com/all.php?name=VTRS) (Medicines manufacturer) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=203686)
(2026-05-07, Before Market Open):

- Revenue -0.3% YoY (vs +4.9% in previous quarter and historical rate -1.5%)
- EBITDA +19.2% YoY (vs -20.3% in previous quarter and historical rate +4.0%)
- EBITDA margin 13.7% increased compared to 11.5% same period last year
- Net Debt decreased by $939 mln over the past reporting period (4.3% of market cap)
- FCF (LTM) +$1 bln (positive), 4.6% of market cap
- EV/EBITDA multiple is 11.8x compared to historical level (75th percentile) of 89.4x
- EV/Sales multiple is 2.3x

2026-11-06
#reports #VRSK

[Verisk Analytics](https://eninvs.com/all.php?name=VRSK) (Analytical service provider) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=203556)
(2026-02-18, Before Market Open):

- Revenue +5.3% YoY (vs +4.3% in previous quarter and historical rate +6.5%)
- EBITDA +4.1% YoY (vs +1.8% in previous quarter and historical rate +4.4%)
- EBITDA margin 60.0% decreased compared to 60.7% same period last year
- Net Debt increased by $10 mln over the past reporting period (0.0% of market cap)
- FCF (LTM) +$0.6 bln (positive), 2.4% of market cap
- EV/EBITDA multiple is 17.8x compared to historical level (75th percentile) of 22.5x
- EV/Sales multiple is 9.7x

2026-11-06
#reports #VIRT

[Virtu Financial](https://eninvs.com/all.php?name=VIRT) (Financial service provider and market maker) reported for 2026 q3
(2026-07-23, Before Market Open):

- Revenue +38.4% YoY (vs +68.3% in previous quarter and historical rate +26.4%)
- Net Income +60.8% YoY (vs +139.5% in previous quarter and historical rate +63.7%)
- Net Income margin 24.5% increased compared to 21.1% same period last year
- P/E multiple is 4x compared to historical level (75th percentile) of 7.4x
- P/S multiple is 1.1x
- Price to book: 2.4x
2026-11-06
#reports #VHI

[Valhi](https://eninvs.com/all.php?name=VHI) (Chemicals) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=203751)
(2026-05-07, After Market Close):

- Revenue +13% YoY (vs +27.1% in previous quarter and historical rate +9.3%)
- EBITDA +229.2% YoY (vs +192.6% in previous quarter and historical rate +85.5%)
- EBITDA margin 13.3% increased compared to 4.6% same period last year
- Net Debt decreased by $37 mln over the past reporting period (9.2% of market cap)
- FCF (LTM) +$0.1 bln (positive), 24.5% of market cap
- EV/EBITDA multiple is 6.2x compared to historical level (75th percentile) of 14x
- EV/Sales multiple is 0.5x

2026-11-06
#reports #VCEL

[Vericel](https://eninvs.com/all.php?name=VCEL) (Medical services provider) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=203795)
(2026-05-07, Before Market Open):

- Revenue +25% YoY (vs +22.2% in previous quarter and historical rate +20.3%)
- EBITDA +150% YoY (vs +300.0% in previous quarter)
- EBITDA margin 17.6% increased compared to 8.8% same period last year
- Net Debt decreased by $10 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) +$0 bln (positive), 1.6% of market cap
- EV/EBITDA multiple is 64.3x compared to historical level (75th percentile) of 665.3x
- EV/Sales multiple is 8x

2026-11-06
#reports #USFD

[US Foods](https://eninvs.com/all.php?name=USFD) (Food services provider) reported for 2026 q3
(2026-05-07, Before Market Open):

- Revenue +2.1% YoY (vs +4.5% in previous quarter and historical rate +4.9%)
- EBITDA +23.5% YoY (vs +15.2% in previous quarter and historical rate +17.7%)
- EBITDA margin 4.7% increased compared to 3.9% same period last year
- Net Debt decreased by $131 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0.5 bln (positive), 2.1% of market cap
- EV/EBITDA multiple is 15.3x compared to historical level (75th percentile) of 14.2x
- EV/Sales multiple is 0.7x

2026-11-06
#reports #UEIC

[Universal Electronics](https://eninvs.com/all.php?name=UEIC) ( Innovative products manufacturer) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=203449)
(2026-05-11, After Market Close):

- Revenue -2.2% YoY (vs -25.5% in previous quarter and historical rate -8.9%)
- EBITDA margin 10.1% increased compared to -1.1% same period last year
- Net Debt decreased by $11 mln over the past reporting period (17.6% of market cap)
- FCF (LTM) -$0 bln (negative), 1.6% of market cap
- EV/EBITDA multiple is 2.3x compared to historical level (75th percentile) of 33.5x
- EV/Sales multiple is 0.1x

2026-11-06
#reports #U

[Unity Software](https://eninvs.com/all.php?name=U) (Software provider) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=203689)
(2026-05-07, Before Market Open):

- Revenue +32.1% YoY (vs +23.8% in previous quarter and historical rate +9.9%)
- EBITDA >1000% YoY (vs +5200.0% in previous quarter and historical rate +66.7%)
- EBITDA margin 29.9% increased compared to 2.1% same period last year
- Net Debt decreased by $286 mln over the past reporting period (1.3% of market cap)
- FCF (LTM) +$0.7 bln (positive), 3.3% of market cap
- EV/Sales multiple is 10x

2026-11-06
#reports #TXG

[10X Genomics](https://eninvs.com/all.php?name=TXG) (Medical services provider) reported for 2026 q3
(2026-05-07, After Market Close):

- Revenue +1.3% YoY (vs -12.7% in previous quarter and historical rate +1.9%)
- EBITDA margin -4.0% increased compared to -14.8% same period last year
- Net Debt decreased by $27 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) +$0.1 bln (positive), 1.0% of market cap
- EV/Sales multiple is 11.7x